Products for Research Use Only
RegisterLogin

Dapirolizumab

CAT: 0804-HY-P99842A-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99842A-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Dapirolizumab is a monoclonal antibodi against CD40 ligand. Dapirolizumab targets CD40L, blocks its interaction with CD40 receptors, and inhibits adaptive immune activation. Dapirolizumab attenuates systemic lupus erythematosus[1].
CAS Number
1416147-64-2
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/dapirolizumab.html
Purity
99.66
Smiles
[Dapirolizumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Furie RA, et al., Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus. Rheumatology (Oxford) . 2021 Nov 3;60 (11) :5397-5407.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T77363-01Dapirolizumab
T82611-01Dapirolizumab pegol
GTR18609101-01Dapirolizumab Antibody
GTR18333425-01Dapirolizumab pegol Antibody
HB199026-01Research Grade Dapirolizumab
E55B1115Dapirolizumab (Reference antibody)
591779Dapirolizumab Pegol (CD40LG, CD154)
KBI1257KRIBIOLISA™ Dapirolizumab Pegol ELISA
GTR18780520-01(Dapirolizumab) Biosimilar Reference Antibody
GTR18697816-01Dapirolizumab Human Monoclonal Antibody

Popular Products